BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15642706)

  • 1. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro.
    Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Lin Q; Pan XL; Song YQ; Zhang MH; Hou M; Chen F
    Ann Oncol; 2005 Mar; 16(3):455-9. PubMed ID: 15642706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J; Lu H; Huang R; Lin D; Wu X; Lin Q; Wu X; Zheng J; Pan X; Peng J; Song Y; Zhang M; Hou M; Chen F
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
    Taba Y; Miyagi M; Miwa Y; Inoue H; Takahashi-Yanaga F; Morimoto S; Sasaguri T
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H38-46. PubMed ID: 12623786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
    Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
    Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
    Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M
    Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof].
    Li SJ; Shang T; Li SY; Li QL
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):174-8. PubMed ID: 17425848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
    Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
    J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
    Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
    Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
    Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
    Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
    Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M; Hasegawa A; Yamamori M; Okamura N
    J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.